Please Wait
Applying Filters...
menu
    • menu

    List of Written Confirmation(s) issued for Alphapharm Brand of Dicloxacillin Sodium Active Pharmaceutical Ingredient (API)

    Client Email Product
    US, Europe turn to advanced manufacturing, stockpiling to strengthen drug supply chains

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    Alphapharm Brand of Dicloxacillin Sodium

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Name of the Firm Written Confirmation No. Product Name Issue Date Valid Till Address of the Firm
    15/03/2022 Centrient Pharmaceuticals
    Netherlands
    		 M/s. DSM Sinochem Pharmaceuticals India Pvt. Ltd., WC-0010 Dicloxacillin Sodium IP/BP/USP/EP 2022-05-19 2025-05-27 Toansa, Dist. Nawanshahar-144 533 Punjab India 
    29/04/2020 Aurobindo Pharma Limited
    India
    		  M/s. Aurobindo Pharma Ltd. WC-0121 Dicloxacillin Sodium (BP/Ph. Eur) 2019-07-05 2022-07-02 Unit-V, Plot No.79-91, IDA, Chemical Zone, Pashamylaram (V), Patancheru (M), Medak (Dist). AP